Musubire, Abdu
Kagimu, Enock
Mugabi, Timothy
Meya, David B.
Boulware, David R.
Bahr, Nathan C.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS086312, R01NS086312, K23 NS110470)
Article History
Accepted: 8 February 2024
First Online: 24 February 2024
Declarations
:
: Drs. Musubire, Kagimu, and Mugabi declare that they have no conflict of interest. Drs. Meya Boulware and Bahr declare grant funding from the NIH. Dr. Bahr also declares that his institution received funds for his role as a PI in an unrelated trial from Karyopharm Therapeutics.
: This article does not contain any studies with human or animal subjects performed by any of <b>the authors</b>.